JPRN-UMIN000010737已完成未知
Phase II Study for Efficacy and Safety of nab-paclitaxel for Previously Treated Advanced Non-small Cell Lung Cancer - Phase II study of nab-PTX for previously treated adnvaced NSCLC
Tokyo Metropolitan Cancer and Infection diseases Center Komagome Hospital0 个研究点目标入组 22 人开始时间: 2013年5月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Previously treated with paclitaxel 2) With uncontrolled brain metastasis 3) With clinically active infection 4) With severe complication (cardiac diseases, interstitial pneumonia, uncontrolled hypertension or diabetes) 5) With uncontrolled pleural effusion 6) With active other organ cancer 7) With the history of severe drug allergy 8) With the history of hypersensivity for paclitaxel, albumin-containing agents 9) With uncontrolled digestive ulcer 10) Any patients judged by the investigator to be unfit to participate in the study
研究者
相似试验
已完成
不适用
Phase 2 prospective study of the efficacy of nab-paclitaxel, carboplatin and bevacizumab for the treatment of stage 3B/4 non-squamous cell and non-small cell lung canceron-squamous cell and non-small cell lung cancerJPRN-UMIN000024610niversity of Fukui30
已完成
2 期
Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast CancerBreast CancerNCT01565499Spanish Breast Cancer Research Group83
已完成
不适用
A phase II study of nab-paclitaxel for pretreated non-small cell lung canceron-small cell lung cancerJPRN-UMIN000012972Kanagawa Cancer Center30
进行中（未招募）
不适用
a multicenter phase II trial of nab-paclitaxel and capecitabine as first line treatment in Her-2 neg. metastatic breast cancerEUCTR2012-000393-35-ITGOIM GRUPPO ONCOLOGICO MERIDIONALE
已完成
2 期
Phase II study of nab-paclitaxel for pretreated NSCLCon-small cell lung cancerJPRN-UMIN000014357Kitasato university hospital, division of respiratory medicine20